Literature DB >> 22832532

Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat.

Christopher T Banek1, Ashley J Bauer, Anne Gingery, Jeffrey S Gilbert.   

Abstract

Increased uterine artery resistance and angiogenic imbalance characterized by increased soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased free vascular endothelial growth factor (VEGF) are often associated with placental insufficiency and preeclampsia but not synonymous with hypertension. We hypothesized chronic reductions in utero-placental perfusion (RUPP) for 5 days (d) during either mid- (d12-d17) or late (d14-d19) gestation would have disparate effects on plasma sFlt-1 and VEGF levels and blood pressure. Five days of chronic RUPP was achieved by placement of silver clips on the abdominal aorta and ovarian arteries on either gestational d12 or d14. Arterial pressure was increased (P < 0.05) in RUPP vs. normal pregnant (NP) in both d17 (10%) and d19 (25%) groups, respectively. Circulating free VEGF was decreased (P < 0.05) and sFlt-1:VEGF ratio increased (P < 0.05) after 5 days of RUPP ending on d19 but not d17 compared with NP controls. Angiogenic imbalance, measured by an endothelial tube formation assay, was present in the d19 RUPP but not the d17 RUPP compared with age-matched NP rats. Five days of RUPP from days 14 to 19 decreased fetal and placental weights 10% (P < 0.01) compared with d19 NP controls. After 5 days of RUPP, from days 12 to 17 of pregnancy, fetal weights were 21% lighter (P < 0.01) compared with d17 NP controls, but placental weight was unchanged. These findings suggest that the timing during which placental insufficiency occurs may play an important role in determining the extent of alterations in angiogenic balance, fetal growth restriction, and the severity of placental ischemia-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832532      PMCID: PMC3468444          DOI: 10.1152/ajpregu.00250.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  46 in total

1.  Male sex bias in placental dysfunction.

Authors:  Ally Murji; Leslie K Proctor; Andrew D Paterson; David Chitayat; Rosanna Weksberg; John Kingdom
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

Review 2.  Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question.

Authors:  S Ananth Karumanchi; Yuval Bdolah
Journal:  Endocrinology       Date:  2004-11       Impact factor: 4.736

3.  Location of the placenta or the umbilical cord insertion site in the lowest uterine segment is associated with low maternal blood pressure.

Authors:  J Hasegawa; A Sekizawa; A Farina; M Nakamura; R Matsuoka; K Ichizuka; T Okai
Journal:  BJOG       Date:  2011-07-12       Impact factor: 6.531

4.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

5.  Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.

Authors:  D Schlembach; W Wallner; R Sengenberger; E Stiegler; M Mörtl; M W Beckmann; U Lang
Journal:  Ultrasound Obstet Gynecol       Date:  2007-04       Impact factor: 7.299

6.  Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.

Authors:  Mona Sedeek; Jeffrey S Gilbert; Babbette B LaMarca; Myssara Sholook; Derrick L Chandler; Yuping Wang; Joey P Granger
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

7.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

Review 8.  Maternal and neonatal outcomes of elective induction of labor.

Authors:  Aaron B Caughey; Vandana Sundaram; Anjali J Kaimal; Yvonne W Cheng; Allison Gienger; Sarah E Little; Jason F Lee; Luchin Wong; Brian L Shaffer; Susan H Tran; Amy Padula; Kathryn M McDonald; Elisa F Long; Douglas K Owens; Dena M Bravata
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2009-03

9.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

Authors:  Fàtima Crispi; Carmen Domínguez; Elisa Llurba; Pilar Martín-Gallán; Luís Cabero; Eduard Gratacós
Journal:  Am J Obstet Gynecol       Date:  2006-03-20       Impact factor: 8.661

10.  Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats.

Authors:  Jeffrey Gilbert; Matt Dukes; Babbette LaMarca; Kathy Cockrell; Sara Babcock; Joey Granger
Journal:  Am J Hypertens       Date:  2007-06       Impact factor: 2.689

View more
  13 in total

1.  AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.

Authors:  Christopher T Banek; Ashley J Bauer; Karen M Needham; Hans C Dreyer; Jeffrey S Gilbert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-15       Impact factor: 4.733

2.  Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.

Authors:  Jeffrey S Gilbert; Christopher T Banek; Ashley J Bauer; Anne Gingery; Karen Needham
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

3.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

4.  Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.

Authors:  Ashley J Bauer; Christopher T Banek; Karen Needham; Haley Gillham; Susan Capoccia; Jean F Regal; Jeffrey S Gilbert
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

5.  Methodological differences account for inconsistencies in reported free VEGF concentrations in pregnant rats.

Authors:  Tracey L Weissgerber; Andrea McConico; Bruce E Knudsen; Kim A Butters; Suzanne R Hayman; Wendy M White; Natasa Milic; Virginia M Miller; Vesna D Garovic
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-12       Impact factor: 3.619

6.  Reduced Uteroplacental Perfusion Pressure (RUPP) causes altered trophoblast differentiation and pericyte reduction in the mouse placenta labyrinth.

Authors:  Bryony V Natale; Prutha Mehta; Priscilla Vu; Christina Schweitzer; Katarina Gustin; Ramie Kotadia; David R C Natale
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

7.  Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system.

Authors:  Julie Hakim; Mary K Senterman; Antoine M Hakim
Journal:  Int J Pediatr       Date:  2013-04-16

Review 8.  Placental disease and the maternal syndrome of preeclampsia: missing links?

Authors:  Dionne Tannetta; Ian Sargent
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

9.  Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice.

Authors:  Tomofumi Fushima; Akiyo Sekimoto; Takahiro Minato; Takuya Ito; Yuji Oe; Kiyomi Kisu; Emiko Sato; Kenichi Funamoto; Toshiyuki Hayase; Yoshitaka Kimura; Sadayoshi Ito; Hiroshi Sato; Nobuyuki Takahashi
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

10.  Supplementing punicalagin reduces oxidative stress markers and restores angiogenic balance in a rat model of pregnancy-induced hypertension.

Authors:  Yujue Wang; Mengwei Huang; Xiaofeng Yang; Zhongmei Yang; Lingling Li; Jie Mei
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.